Stability and development of psychotic symptoms and the use of antipsychotic medication - long-term follow-up

D R Gotfredsen, R S Wils, C Hjorthøj, S F Austin, N Albert, R G Secher, A A E Thorup, O Mors, M Nordentoft

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


BACKGROUND: Few studies have evaluated the development in the use of antipsychotic medication and psychotic symptoms in patients with first-episode psychosis on a long-term basis. Our objective was to investigate how psychotic symptoms and the use of antipsychotic medication changed over a 10-year period in a cohort of patients with first-episode psychosis.

METHOD: The study is a longitudinal prospective cohort study over 10 years with follow-ups at years 1, 2, 5 and 10. A total of 496 patients with first-episode psychosis were included in a multi-centre study initiated between 1998 and 2000 in Copenhagen and Aarhus, Denmark.

RESULTS: At all follow-ups, a large proportion (20-30%) of patients had remission of psychotic symptoms without use of antipsychotic medication at the time of the follow-up. Patients who were in this group at the 5-year follow-up had an 87% [95% confidence interval (CI) 77-96%] chance of being in the same group at the 10-year follow-up. This stability was also the case for patients who had psychotic symptoms and were treated with antipsychotic medication at year 5, where there was a 67% (95% CI 56-78%) probability of being in this group at the consecutive follow-up.

CONCLUSIONS: A large group of patients with psychotic illness were in remission without the use of antipsychotic medication, peaking at year 10. Overall there was a large degree of stability in disease courses over the 10-year period. These results suggest that the long-term outcome of psychotic illness is heterogeneous and further investigation on a more individualized approach to long-term treatment is needed.

TidsskriftPsychological Medicine
Udgave nummer12
Sider (fra-til)2118-2129
StatusUdgivet - sep. 2017
Udgivet eksterntJa


Dyk ned i forskningsemnerne om 'Stability and development of psychotic symptoms and the use of antipsychotic medication - long-term follow-up'. Sammen danner de et unikt fingeraftryk.